Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Osteoporosis, Postmenopausal
- A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.
- Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis
- Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2
- Efficacy and Safety of Minodronate in Patients With Low Back Pain
- Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women
- Effect of Laser Acupuncture on Forearm Bone Mineral Density and Wrist Pain in Osteoporotic Postmenopausal Women: A Randomized Controlled Trial
- Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease
- Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis
- Effectiveness and Safety of EuBone® Capsules for Bone Health in Postmenopausal Women
- Randomized, Double-Blind, Parallel Design, 2-arm,Multicenter Study Assessing the Biosimilarity of AVT03 and US-Prolia® in Postmenopausal Women With Osteoporosis
- Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis
- Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
- Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients
- MAGnesium Effect With ANtiosteoporotic Drugs
- Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis
- Use of Ibandronate in Diabetic Patients
- Efficacy and Safety of MW031 in PMO Subjects
- Comparative Efficacy and Safety Study of RGB-14-P and Prolia in Women With Postmenopausal Osteoporosis
- A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture
- Romosozumab Use to Build Skeletal Integrity
- Anabolic Therapy in Postmenopausal Osteoporosis
- Effect of GLP-1 Receptor Agonists on Trabecular Bone Score and Visceral Adiposity in Postmenopausal Women With Type 2 Diabetes Mellitus.
- Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults
- A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis
- The Effects of Melatonin Treatment on Bone, Marrow, Sleep and Blood Pressure
- Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW031 and Prolia® in Healthy Adults
- Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid
- Pravastatin Reduces Acute Phase Response of Zoledronic Acid
- A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis
- Pearlium®/Effecti-Cal®, a Novel Formulation of Calcium, Vitamin D and Minerals for Prevention of Postmenopausal Bone Loss
- Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® .
- Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
- A Multiple Dose Study to Evaluate the Effect of SHR-1222 Injection in Postmenopausal Osteoporosis Patients
- Blackcurrant Modifies Gut Microbiota and Reduces Osteoporosis Risk
- Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate
- Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis
- Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk
- Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
- Phase 1 Study to Compare CMAB807 Injection to Prolia® in Healthy Volunteers
- Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
- Comparative Antiresorptive Efficacy Discontinuation of Denosumab
- Clinical Study on Treatment of Postmenopausal Osteoporosis (Kidney Deficiency and Blood Stasis Syndrome) With Xulin Jiangu Granules
- A Clinical Trial to Evaluate the Safety and Pharmacokinetic
- MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis
- A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
- Effect of VSL#3 on Bone Mineral Density in Postmenopausal Women
- Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic Women
- The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP)
- A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis
- Preventing Osteoporosis Using Denosumab
- A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
- A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis
- PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia
- A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis
- Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)
- Denosumab Safety Assessment in Multiple Observational Databases
- Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation
- A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen
- Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication
- Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France
- Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis
- Denosumab and Teriparatide Study (DATA-HD and DATA-EX)
- A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
- A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants
- Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women
- A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis
- Denosumab China Phase III Study
- Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis
- Safety Study of an Oral Vitamin D Analog in Postmenopausal Women
- Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo
- Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1
- An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women
- Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal Osteoporosis
- Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
- Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis
- VERtebral Fracture Treatment Comparisons in Osteoporotic Women
- Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis
- Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis
- Transition From Alendronate to Romosozumab (AMG 785)
- Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis
- Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass
- Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)
- Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis
- A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab
- A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab
- Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)
- Wellnara Post-marketing Surveillance in Japan
- Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan
- Julina Post-marketing Surveillance for Climacteric Symptoms in Japan
- A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)
- Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis
- Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women
- Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women
- A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis
- A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis
- A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women
- Vitamin K as Additive Treatment in Osteoporosis
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women
- The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam
- A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis
- Angeliq Regulatory Post Marketing Surveillance
- MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)
- Intra-venous Zoledronic Acid Once Yearly
- A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation
- A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women
- A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates
- Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women
- Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women
- A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years
- Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density
- A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab
- A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
- A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women
- Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation
- Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)
- 3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs
- A Study for Teriparatide in Severe Osteoporosis
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects
- The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation
- Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
- Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis
- Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects
- A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis
- Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)
- Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO
- A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide
- A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
- Satisfaction and Compliance of Risedronate in PMO
- POWER Point of Care Effect on Satisfaction of Treatment
- BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis
- BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
- SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
- A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)
- ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
- A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.
- PTH Comparison in Post Menopausal Women
- A Study of the Treatment of Postmenopausal Women With Osteoporosis
- Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
- A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis
- Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)
- Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
- Long Term Effects of Raloxifene Treatment on Bone Quality
- Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo
- Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
- A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)
- PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)
- A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
- A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
- Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women
- Risedronate Sodium in Post Menopausal Osteoporosis
- Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women
- Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
- Risedronate in the Prevention of Osteoporosis in Postmenopausal Women
- FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)
- A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)
- Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women
- A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)
- Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis
- Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.
- Study of Transitioning From Alendronate to Denosumab
- A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
- Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women
- The Effects of Potassium Citrate on Bone Metabolism
- Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women
- Risedronate in Postmenopausal Women With Low Bone Density
- Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis
- A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
- A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density
- Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause
- Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)
- A Study of Monthly Risedronate for Osteoporosis
- Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
- Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.
- 3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women
- Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
- 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
- A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis
- TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
- Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)
- Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women
- Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy
- Texture Analysis for Postmenopausal Osteoporosis
- OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women
- Study of Investigational Drug in Osteoporosis (MK-0217-908)
- A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)
- A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)
- A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)
- Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
- A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis
- Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer
- Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women
- Effects of Arzoxifene on Bone Mass and the Uterus
- A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
- Effects of Teriparatide in Postmenopausal Women With Osteoporosis
- DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
- MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
- Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
- Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
- Combination Osteogenic Therapy in Established Osteoporosis
- Effects of Black Cohosh on Menopausal Hot Flashes